Recursion Pharmaceuticals is an emerging biotechnology company that combines experimental biology, automation, and artificial intelligence in a massively parallel system to quickly and efficiently identify treatments for any disease which can be modeled at the cellular level. Recursion’s platform has been used to identify potential new treatments for genetic, inflammatory and oncological diseases, and is being applied broadly in additional areas of biology including infectious disease and diseases of aging. Founded in 2013, Recursion’s tech-first approach will enable treatments for diseases in a fraction of the typical timeframe and at a fraction of the cost and ultimately lead the company in building a roadmap of human cellular biology.
